12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
,3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood rgas ranalysis ris rused rwith rpatients rwith rCOPD rto rdo rwhich rof
rthe rfollowing?
a. Monitor rairway rresponsiveness.
b. Determine rlevel rof rcardiopulmonary rfitness.
c. Detect rpulmonary rhypertension.
d. Assess rneed rfor rsupplementary rO2.
ANS: rD
Blood rgas ranalysis ris rmost rcommonly rused rto rdetermine rthe rneed rfor rsupplemental
roxygen rand rto rmanage rpatients rwho rrequire rventilatory rsupport.
DIF: 2 REF: p. r15 OBJ: EL-1
rMSC: rNBRC: rCPFT r2A-2
6. Which rof rthe rfollowing rcause remphysema?
1. 1- rAntitrypsin rdeficiency
2. Exposure rto renvironmental rpollutants
3. Radiation rtherapy
4. Cigarette rsmoking
a. 1 r and r 2
b. 3 r and r 4
c. 1 r, r2, rand r 4
d. 2 r, r3, rand r 4
ANS: rC
Emphysema ris rcaused rprimarily rby rcigarette rsmoking. rSome remphysema ris rcaused rby rthe
rabsence rof ra rprotective renzyme. rChronic rexposure rto renvironmental rpollutants rcan ralso
rcontribute rto rthe rdevelopment rof remphysema.
DIF: 1 REF: p. r11 OBJ: EL-3 r| rAL-2 MSC: rNBRC: rNone
7. An radult rpatient rcomplains rof rchest rtightness rand rcough rwhenever rhe rjogs rin rcold
rweather. rThese rsymptoms rare rconsistent rwith rwhich rof rthe rfollowing?
a. Cystic rfibrosis
b. Asthma
c. Pulmonary rhypertension
d. Idiopathic rpulmonary rfibrosis
|